California Insurance Commissioner Sues AbbVie, Alleging 'Kickbacks' for Humira
September 18 2018 - 4:03PM
Dow Jones News
By Josh Beckerman
California Insurance Commissioner Dave Jones sued AbbVie Inc.
(ABBV), alleging the company made "illegal kickbacks" to
health-care providers to encourage prescriptions of Humira.
AbbVie said the allegations are without merit.
Humira, one of the world's top-selling drugs, treats conditions
including rheumatoid arthritis, Crohn's disease and psoriasis.
Mr. Jones, who filed a complaint in Alameda County Superior
Court, alleges the company's "Ambassador" program was intended to
"keep patients on a dangerous drug at any cost."
AbbVie said in a statement that it "operates in compliance with
the many state and federal laws that govern interactions with
healthcare providers and patients."
The company said it "provides a number of support services for
patients, once they are prescribed Humira, that both educate and
assist patients with their therapy, including nursing support, and
these resources are beneficial to patients dealing with a chronic
condition."
AbbVie shares recently traded down 2.9%, to $92.60.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
September 18, 2018 15:48 ET (19:48 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Aug 2024 to Sep 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Sep 2023 to Sep 2024